Digital system for cancer medication is now fully rolled out across Norway
Norwegian hospitals have now completed the implementation of a new digital system for managing cancer medications. The system, called Omda Cytodose, is now in use across all health regions in the country. This marks an important milestone for the digitalization of Norwegian cancer care.
Omda Cytodose is software that helps healthcare professionals plan and administer the correct dosage of chemotherapy and other cancer medications. By using this system, hospitals can ensure that patients receive exactly the treatment they need, while simultaneously reducing the risk of errors.
The software has already established itself as the leading solution for cancer medication in both Norway and Sweden. The fact that the system is now fully rolled out regionally in Norway means that all hospital departments treating cancer patients are now utilizing the same technology.
The introduction of digital tools in the healthcare sector is part of a larger commitment to patient safety and efficiency. By consolidating information into one system, it becomes easier for doctors and nurses to collaborate on patient care across different departments.
With the completion of this project, Norway is now well-equipped for the future of cancer treatment. The system is expected to contribute to a safer everyday life for both healthcare staff and the patients receiving treatment at Norwegian hospitals.